Segment Information (Tables)
|
9 Months Ended |
Sep. 30, 2020 |
Segment Reporting [Abstract] |
|
Schedule of reportable business segment information |
Reportable business segment information is as follows (dollar amounts in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
|
2020 |
|
2019 |
|
2020 |
|
2019 |
Net sales: |
|
|
|
|
|
|
|
Asia |
$ |
38,099 |
|
|
$ |
33,717 |
|
|
$ |
101,814 |
|
|
$ |
102,475 |
|
Europe |
18,006 |
|
|
14,640 |
|
|
54,098 |
|
|
45,312 |
|
North America |
37,557 |
|
|
34,161 |
|
|
110,785 |
|
|
105,304 |
|
Latin America and Other |
6,588 |
|
|
6,006 |
|
|
16,765 |
|
|
17,429 |
|
Total net sales |
100,250 |
|
|
88,524 |
|
|
283,462 |
|
|
270,520 |
|
|
|
|
|
|
|
|
|
Contribution margin (1): |
|
|
|
|
|
|
|
Asia |
17,981 |
|
|
16,236 |
|
|
48,560 |
|
|
48,638 |
|
Europe |
5,954 |
|
|
4,865 |
|
|
17,987 |
|
|
14,692 |
|
North America |
12,065 |
|
|
12,169 |
|
|
38,388 |
|
|
37,587 |
|
Latin America and Other |
2,765 |
|
|
2,608 |
|
|
7,161 |
|
|
7,348 |
|
Total contribution margin |
38,765 |
|
|
35,878 |
|
|
112,096 |
|
|
108,265 |
|
|
|
|
|
|
|
|
|
Selling, general and administrative expenses (2) |
33,294 |
|
|
31,177 |
|
|
92,863 |
|
|
96,048 |
|
Operating income |
5,471 |
|
|
4,701 |
|
|
19,233 |
|
|
12,217 |
|
|
|
|
|
|
|
|
|
Other income (loss), net |
671 |
|
|
(1,243) |
|
|
(230) |
|
|
(985) |
|
Income before provision for income taxes |
$ |
6,142 |
|
|
$ |
3,458 |
|
|
$ |
19,003 |
|
|
$ |
11,232 |
|
_________________________________________
(1) Contribution margin consists of net sales less cost of sales and volume incentives expense.
(2) Service fees in China totaled $3.2 million and $8.0 million for the three and nine-month periods ended September 30, 2020, respectively, compared to $2.8 million and $7.3 million for the three and nine-month periods ended September 30, 2019. These service fees are included in selling, general and administrative expenses.
|
Schedule of consolidated net sales revenue by geographical locations |
From an individual country perspective, the United States and South Korea comprise 10 percent or more of consolidated net sales for the three and nine-month periods ended September 30, 2020 and 2019, as follows (dollar amounts in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
|
2020 |
|
2019 |
|
2020 |
|
2019 |
Net sales: |
|
|
|
|
|
|
|
United States |
$ |
35,062 |
|
|
$ |
31,579 |
|
|
$ |
103,048 |
|
|
$ |
97,734 |
|
South Korea |
16,592 |
|
|
15,226 |
|
|
47,447 |
|
|
52,677 |
|
Other |
48,596 |
|
|
41,719 |
|
|
132,967 |
|
|
120,109 |
|
|
$ |
100,250 |
|
|
$ |
88,524 |
|
|
$ |
283,462 |
|
|
$ |
270,520 |
|
|
Schedule of revenue generated by each of the Company's product lines |
Net sales generated by each of our product lines is set forth below (dollar amounts in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
|
2020 |
|
2019 |
|
2020 |
|
2019 |
Asia |
|
|
|
|
|
|
|
General health |
$ |
10,055 |
|
|
$ |
9,450 |
|
|
$ |
27,364 |
|
|
$ |
28,287 |
|
Immune |
85 |
|
|
105 |
|
|
465 |
|
|
462 |
|
Cardiovascular |
10,622 |
|
|
9,997 |
|
|
29,284 |
|
|
33,390 |
|
Digestive |
9,935 |
|
|
6,309 |
|
|
24,482 |
|
|
18,417 |
|
Personal care |
2,575 |
|
|
3,472 |
|
|
7,457 |
|
|
9,559 |
|
Weight management |
4,827 |
|
|
4,384 |
|
|
12,762 |
|
|
12,360 |
|
|
38,099 |
|
|
33,717 |
|
|
101,814 |
|
|
102,475 |
|
Europe |
|
|
|
|
|
|
|
General health |
$ |
7,725 |
|
|
$ |
5,232 |
|
|
$ |
22,501 |
|
|
$ |
16,352 |
|
Immune |
1,510 |
|
|
1,176 |
|
|
5,324 |
|
|
3,539 |
|
Cardiovascular |
2,581 |
|
|
2,433 |
|
|
7,693 |
|
|
8,050 |
|
Digestive |
4,541 |
|
|
3,374 |
|
|
13,254 |
|
|
10,555 |
|
Personal care |
1,023 |
|
|
1,905 |
|
|
3,492 |
|
|
5,065 |
|
Weight management |
626 |
|
|
520 |
|
|
1,834 |
|
|
1,751 |
|
|
18,006 |
|
|
14,640 |
|
|
54,098 |
|
|
45,312 |
|
North America |
|
|
|
|
|
|
|
General health |
$ |
15,839 |
|
|
$ |
14,823 |
|
|
$ |
46,190 |
|
|
$ |
45,505 |
|
Immune |
5,790 |
|
|
3,731 |
|
|
18,637 |
|
|
11,289 |
|
Cardiovascular |
4,138 |
|
|
4,780 |
|
|
11,984 |
|
|
14,791 |
|
Digestive |
8,635 |
|
|
7,946 |
|
|
24,734 |
|
|
25,190 |
|
Personal care |
1,963 |
|
|
1,617 |
|
|
5,867 |
|
|
4,563 |
|
Weight management |
1,192 |
|
|
1,264 |
|
|
3,373 |
|
|
3,966 |
|
|
37,557 |
|
|
34,161 |
|
|
110,785 |
|
|
105,304 |
|
Latin America and Other |
|
|
|
|
|
|
|
General health |
$ |
2,038 |
|
|
$ |
1,929 |
|
|
$ |
5,002 |
|
|
$ |
5,324 |
|
Immune |
837 |
|
|
664 |
|
|
2,326 |
|
|
1,874 |
|
Cardiovascular |
429 |
|
|
378 |
|
|
1,070 |
|
|
1,078 |
|
Digestive |
2,682 |
|
|
2,499 |
|
|
7,008 |
|
|
7,680 |
|
Personal care |
384 |
|
|
267 |
|
|
848 |
|
|
784 |
|
Weight management |
218 |
|
|
269 |
|
|
511 |
|
|
689 |
|
|
6,588 |
|
|
6,006 |
|
|
16,765 |
|
|
17,429 |
|
|
$ |
100,250 |
|
|
$ |
88,524 |
|
|
$ |
283,462 |
|
|
$ |
270,520 |
|
|
Schedule of consolidated property, plant and equipment by geographical locations |
From an individual country perspective, only the United States comprised 10 percent or more of consolidated property, plant and equipment as follows (dollar amounts in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, 2020 |
|
December 31, 2019 |
Property, plant and equipment: |
|
|
|
United States |
$ |
52,129 |
|
|
$ |
54,470 |
|
Other |
4,035 |
|
|
5,042 |
|
Total property, plant and equipment, net |
$ |
56,164 |
|
|
$ |
59,512 |
|
|
Schedule of assets per segment |
Total assets per segment is set forth below (dollar amounts in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, 2020 |
|
December 31, 2019 |
Assets: |
|
|
|
Asia |
$ |
80,613 |
|
|
$ |
65,959 |
|
Europe |
18,476 |
|
|
15,187 |
|
North America |
129,573 |
|
|
124,337 |
|
Latin America and Other |
8,758 |
|
|
7,585 |
|
Total assets |
$ |
237,420 |
|
|
$ |
213,068 |
|
|